Dashboard E. coli
Repurposing candidates for E. coli
Escherichia coli
Approved medicines with AI-predicted activity ≥40% against E. coli, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 467
- Existing antimicrobials set aside
- 103
- Needing review
- 28
- Repurposing candidates
- 336
Repurposing candidates for E. coli
AI prediction · nothing measuredAll 336 repurposing candidates for E. coli.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Dapiprazole HydrochlorideExisting use: Glaucoma, Mydriasis, Open-angle glaucoma44.0% AI-predicted activityagainst E. coliNo documented evidence found
- Anileridine PhosphateExisting use: Opioid anesthetics44.0% AI-predicted activityagainst E. coliNo documented evidence found
- RelugolixExisting use: Metastatic prostate cancer, Neoplasm, Prostate adenocarcinoma and 1 more43.9% AI-predicted activityagainst E. coli50+ registered studies
- ZuranoloneExisting use: Depressive disorder, Major depressive disorder, Postpartum depression43.8% AI-predicted activityagainst E. coli17 registered studies
- Rezafungin AcetateExisting use: Candidemia, Candidiasis, Candidiasis, Invasive43.8% AI-predicted activityagainst E. coli5 registered studies
- Naldemedine TosylateExisting use: Constipation, Constipation disorder43.7% AI-predicted activityagainst E. coli1 registered study
- Vorapaxar SulfateExisting use: Myocardial infarction, Peripheral arterial disease, Recurrent thrombophlebitis and 1 more43.7% AI-predicted activityagainst E. coli15 registered studies
- Asciminib HydrochlorideExisting use: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic myelogenous leukemia, Neoplasm43.7% AI-predicted activityagainst E. coliNo documented evidence found
- InavolisibExisting use: Breast cancer, Breast neoplasm43.7% AI-predicted activityagainst E. coli36 registered studies
- Landiolol HydrochlorideExisting use: Atrial fibrillation, Atrial flutter, Supraventricular tachycardia43.7% AI-predicted activityagainst E. coli6 registered studies
- AvacopanExisting use: Anti-neutrophil antibody associated vasculitis, Anti-neutrophil cytoplasmic antibody-associated vasculitis, Granulomatosis with Polyangiitis and 1 more43.6% AI-predicted activityagainst E. coli26 registered studies
- Nefazodone HydrochlorideExisting use: Major depressive disorder43.6% AI-predicted activityagainst E. coli6 registered studies
- FlumazenilExisting use: Antidotes43.6% AI-predicted activityagainst E. coli50+ registered studies
- Tenapanor HydrochlorideExisting use: Constipation, Constipation disorder, Irritable bowel syndrome43.6% AI-predicted activityagainst E. coli2 registered studies
- Fosaprepitant DimeglumineExisting use: Cancer, Chemotherapy-induced nausea and vomiting, Nausea and 3 more43.5% AI-predicted activityagainst E. coli21 registered studies
- Sunitinib MalateExisting use: Cancer, Clear cell renal carcinoma, Gastrointestinal stromal tumor and 6 more43.5% AI-predicted activityagainst E. coli50+ registered studies
- Trazodone HydrochlorideExisting use: Depressive disorder, Major depressive disorder43.5% AI-predicted activityagainst E. coli50+ registered studies
- Donepezil HydrochlorideExisting use: Alzheimer disease, Dementia43.4% AI-predicted activityagainst E. coli50+ registered studies
- EtravirineExisting use: HIV infection, HIV-1 infection, Viral disease43.4% AI-predicted activityagainst E. coli50+ registered studies
- OmeprazoleExisting use: Duodenal ulcer, Dyspepsia, Esophagitis and 5 more43.3% AI-predicted activityagainst E. coli50+ registered studies
- Esomeprazole SodiumExisting use: Ankylosing spondylitis, Duodenal ulcer, Esophagitis and 5 more43.3% AI-predicted activityagainst E. coli46 registered studies
- Pasireotide PamoateExisting use: Acromegaly, Pituitary-dependent Cushing's disease43.3% AI-predicted activityagainst E. coli1 registered study
- EntecavirExisting use: Chronic hepatitis B virus infection, Hepatitis B virus infection, Liver disease and 1 more43.3% AI-predicted activityagainst E. coli50+ registered studies
- Azilsartan KamedoxomilExisting use: Hypertension, Stroke43.2% AI-predicted activityagainst E. coli1 registered study